Nasdaq

Baxter Launches PrisMax 2 System to Advance Critical Care Delivery for Patients and Hospitals

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of PrisMax 2, the latest version of the company’s ...
Business Wire

Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies

Innovative features inspired by clinician feedback make delivering therapy simpler and more efficient Incorporates the latest technology to increase accuracy and performance in delivering therapy for ...
Nasdaq

Baxter's (BAX) PrisMax 2 to Simplify Organ Support Therapies

Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Becker's Hospital Review

Hamilton Health Care will be 1st in US to use PrisMax ICU therapy delivery platform

Deerfield, Ill.-based medical device maker Baxter International announced Aug. 13 that Hamilton Health Care System in Dalton, Ga., will be the first in the U.S. to deploy the PrisMax technology system ...
BioWorld

Miromatrix, Baxter partner on bioengineered liver replacement system

Baxter International Inc. has joined forces with Miromatrix Medical Inc. to advance the development of bioengineered organs for patients with acute liver failure (ALF). Under the collaborative ...